Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Much Was The Sexually Transmitted Infections (STIs) Market Worth In 2025, And What Is Its Anticipated Value By 2029?
The sexually transmitted infections (STIs) market size has seen substantial growth in recent years. This market is anticipated to expand from $63.69 billion in 2024 to $71.28 billion by 2025, exhibiting a compound annual growth rate (CAGR) of 11.9%. In the past, this expansion was largely influenced by factors such as behavioral trends, increased education and awareness, better access to healthcare, and advancements in antibiotic development.
The sexually transmitted infections (STIs) market is projected for significant expansion in the upcoming years. This market is expected to reach $112.02 billion by 2029, achieving a compound annual growth rate (CAGR) of 12.0%. The anticipated growth during the forecast period is driven by factors such as the emergence of new STI strains, various vaccination initiatives, the increasing use of telemedicine and at-home testing, and a focus on sexual health equity. Prominent trends expected in this period include the escalating issue of antimicrobial resistance, the wider implementation of pre-exposure prophylaxis (PrEP), advancements in STI self-management, and enhanced sexual education efforts.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13047&type=smp
Which Drivers Are Impacting The Sexually Transmitted Infections (STIs) Market?
The anticipated expansion of the sexually transmitted infections (STIs) market is driven by an increase in government efforts to raise awareness regarding STIs. A government initiative refers to a program or policy enacted to achieve a specific objective and resolve identified issues. Governments introduce various initiatives aimed at the prevention, control, and treatment of sexually transmitted infections (STIs), including funding for public awareness campaigns, provision of vaccines for specific STIs, and access to free or affordable screening and testing services. As an example, in April 2023, Springfield-Greene County Health, a US-based public health department, launched a new program called Disease Intervention Specialist (DIS) in collaboration with the Missouri Department of Health and Senior Services (Missouri DHSS). This initiative aims to address the growing incidence of sexually transmitted infections (STIs) within Greene County. The two specialists within the DIS program, whose primary focus will be on syphilis and HIV, will reach out to individuals who test positive for these conditions, link them to available treatment options, and assist in identifying and contacting others to inform them about the infection. Consequently, the increased governmental initiatives are set to propel the sexually transmitted infections (STIs) market.
What Are The Different Segment Classifications Within The Sexually Transmitted Infections (STIs) Market?
The sexually transmitted infections (stis)market covered in this report is segmented –
1) By Type: Human Immunodeficiency Virus (HIV); Human Papilloma Virus (HPV); Gonorrhea; Syphilis; Other Types
2) By Treatment: Antibiotics; Antiviral
3) By Location Of Testing: Laboratory Testing; Point-Of-Care (POC) Testing
4) By Route Of Administration: Oral; Parenteral; Other Route Of Administration
5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users
Subsegments:
1) By Human Immunodeficiency Virus (HIV): HIV Type 1; HIV Type 2
2) By Human Papilloma Virus (HPV): Low-Risk HPV; High-Risk HPV
3) By Gonorrhea: Uncomplicated Gonorrhea; Complicated Gonorrhea
4) By Syphilis: Primary Syphilis; Secondary Syphilis; Tertiary Syphilis
5) By Other Types: Chlamydia; Herpes Simplex Virus (HSV); Hepatitis B; Hepatitis C; Trichomoniasis
Which Trends Are Impacting The Sexually Transmitted Infections (STIs) Market?
Leading companies within the sexually transmitted infections (STIs) market are developing innovative offerings that incorporate fluorescent PCR technology to gain a competitive edge. Fluorescent PCR (Polymerase Chain Reaction) technology is a molecular biology method used to identify and quantify specific DNA sequences in a biological sample. For example, in March 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a China-based provider of molecular diagnostic solutions, introduced two new polymer chain reaction (PCR) kits: the Mycoplasma Hominis Real-Time PCR Kit and the Treponema Pallidum Real-Time PCR Kit. These kits present a comprehensive PCR solution for the early diagnosis of sexually transmitted illnesses, which affect numerous individuals. The BioPerfectus Mycoplasma Hominis Real-Time PCR Kit is a reagent that utilizes fluorescent PCR technology to identify Mycoplasma hominis in human male urethral swabs, female cervical or vaginal swabs, and urine samples. The BioPerfectus Treponema Pallidum Real-Time PCR Kit is engineered to detect treponema pallidum nucleic acid in human serum and plasma.
Which Major Firms Are Strengthening Their Position In The Sexually Transmitted Infections (STIs) Industry?
Major companies operating in the sexually transmitted infections (stis) market are Pfizer Inc., Johnson & Johnson, Roche Holdings AG, Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb, Astra Zeneca Pharmaceuticals LP, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Co. Ltd., Hetero Drugs Ltd., Eisai Co. Ltd., Boehringer Ingelheim Group, Sun Pharmaceutical Industries Ltd., Lupin Limited, Dr. Reddy’s Laboratories, Wockhardt Ltd., Zydus Lifescience Ltd., Glenmark Pharmaceuticals Ltd., Cipla Ltd., Torrent Pharmaceuticals Ltd., Otsuka Pharmaceutical Co. Ltd.
Download The Full Report For Exclusive Market Findings:
What Are The Regional Market Dynamics Impacting The Sexually Transmitted Infections (STIs) Industry?
North America was the largest region in the sexually transmitted infection (STIs) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sexually transmitted infections (STIs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Request A Customized Version Of The Sexually Transmitted Infections (STIs) Market Report:
https://www.thebusinessresearchcompany.com/customise?id=13047&type=smp
Browse Through More Reports Similar to the Global Sexually Transmitted Infections (STIs) Market 2025, By The Business Research Company
Std Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/std-diagnostics-global-market-report
Hormonal Contraceptives Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report
Drugs For Erectile Dysfunction Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model